Submitted by Dr Hayley B. Wo... on Thu, 20/01/2022 - 11:08
The Cambridge Cancer Research Hospital (CCRH) project has now had the first stage of its business case (the Strategic Outline Case) approved by the Department for Health and Social Care and NHS England & NHS Improvement.
The approval of the Strategic Outline Case provides backing for the CCRH scheme as part of the government’s commitment to build 40 new hospitals by 2030, with construction set to begin in 2023.
CCRH is a partnership between Cambridge University Hospitals and the University of Cambridge to build a new specialist cancer hospital. It will combine cutting-edge NHS clinical space with three new research institutes that will support the ambitions set out in the government's Life Sciences Strategy, and the NHS Long Term Plan.
Bringing together world-class NHS clinicians with cutting-edge University and industry-led research, CCRH will accelerate the early detection of cancer and lead the way in delivering bespoke, precision treatments that will radically improve patient outcomes.
This one-of-a-kind research hospital supports the government’s ambitions to enable more early diagnosis and help the UK become a ‘testbed for oncology innovation’.
Professor Richard Gilbertson, Head of Department of Oncology, University of Cambridge and Director of Cancer Research UK Cambridge Centre, said: “By locating research at the heart of our hospital and clinical spaces we can change the story of cancer for our patients locally and deliver real hope for people across the globe.”
For more information about the Cambridge Cancer Research Hospital click here.